Paeoniflorin inhibits doxorubicin-induced cardiomyocyte apoptosis by downregulating microRNA-1 expression

  • Authors:
    • Jian‑Zhe Li
    • Xiu‑Neng Tang
    • Ting‑Ting Li
    • Li‑Juan Liu
    • Shu‑Yi Yu
    • Guang‑Yu Zhou
    • Qing‑Rui Shao
    • Hui‑Ping Sun
    • Cheng Wu
    • Yang Yang
  • View Affiliations

  • Published online on: March 24, 2016     https://doi.org/10.3892/etm.2016.3182
  • Pages: 2407-2412
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Doxorubicin (DOX) is an effective anthracycline anti-tumor antibiotic. Because of its cardiotoxicity, the clinical application of DOX is limited. Paeoniflorin (PEF), a monoterpene glucoside extracted from the dry root of Paeonia, is reported to exert multiple beneficial effects on the cardiovascular system. The present study was designed to explore the protective effect of PEF against DOX‑induced cardiomyocyte apoptosis and the underlying mechanism. In cultured H9c2 cells, PEF (100 µmol/l) was added for 2 h prior to exposure to DOX (5 µmol/l) for 24 h. Cell viability, creatine kinase activity, cardiomyocyte apoptosis, intracellular reactive oxygen species (ROS) levels, and the expression of microRNA‑1 (miR‑1) and B‑cell lymphoma 2 (Bcl‑2) were measured following treatment with PEF and/or DOX. The results showed that treatment with DOX notably induced cardiomyocyte apoptosis, concomitantly with enhanced ROS generation, upregulated miR‑1 expression and downregulated Bcl‑2 expression. These effects of DOX were significantly inhibited by pretreatment of the cells with PEF. These results suggest that the inhibitory effect of PEF on DOX-induced cardiomyocyte apoptosis may be associated with downregulation of miR-1 expression via a reduction in ROS generation.
View Figures
View References

Related Articles

Journal Cover

June-2016
Volume 11 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li JZ, Tang XN, Li TT, Liu LJ, Yu SY, Zhou GY, Shao QR, Sun HP, Wu C, Yang Y, Yang Y, et al: Paeoniflorin inhibits doxorubicin-induced cardiomyocyte apoptosis by downregulating microRNA-1 expression. Exp Ther Med 11: 2407-2412, 2016
APA
Li, J., Tang, X., Li, T., Liu, L., Yu, S., Zhou, G. ... Yang, Y. (2016). Paeoniflorin inhibits doxorubicin-induced cardiomyocyte apoptosis by downregulating microRNA-1 expression. Experimental and Therapeutic Medicine, 11, 2407-2412. https://doi.org/10.3892/etm.2016.3182
MLA
Li, J., Tang, X., Li, T., Liu, L., Yu, S., Zhou, G., Shao, Q., Sun, H., Wu, C., Yang, Y."Paeoniflorin inhibits doxorubicin-induced cardiomyocyte apoptosis by downregulating microRNA-1 expression". Experimental and Therapeutic Medicine 11.6 (2016): 2407-2412.
Chicago
Li, J., Tang, X., Li, T., Liu, L., Yu, S., Zhou, G., Shao, Q., Sun, H., Wu, C., Yang, Y."Paeoniflorin inhibits doxorubicin-induced cardiomyocyte apoptosis by downregulating microRNA-1 expression". Experimental and Therapeutic Medicine 11, no. 6 (2016): 2407-2412. https://doi.org/10.3892/etm.2016.3182